Latest Articles

Publication Date
Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer - BioSpace

Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer BioSpace

Published: May 19, 2026, 11:19 a.m.
Cyclana Bio Granted Health Research Authority Approval and Recruits First Patients for Clinical Observational Study in Endometriosis - BioSpace

Cyclana Bio Granted Health Research Authority Approval and Recruits First Patients for Clinical Observational Study in Endometriosis BioSpace

Published: May 19, 2026, 11:15 a.m.
Acer Aspire Vero 16: $320 off at Best Buy - Mashable

Acer Aspire Vero 16: $320 off at Best Buy Mashable

Published: May 19, 2026, 9 a.m.
Women face $1200 bill as key endo drug axed from PBS - Gold Coast Bulletin

Women face $1200 bill as key endo drug axed from PBS Gold Coast Bulletin

Published: May 19, 2026, 7:50 a.m.
Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ - Chosunbiz

Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ Chosunbiz

Published: May 19, 2026, 6:54 a.m.
Hypoxia-mediated epigenetic silencing of YTHDF2 promotes endometriosis progression via the NFE2L1-NF-κB axis.

Endometriosis (EMs) is a chronic inflammatory disease characterized by ectopic growth of endometrial-like tissues. N6-methyladenosine (m6A) modification regulates diverse cellular processes, yet its role in EMs remains unclear. Here, we …

Published: May 19, 2026, midnight
Hormonal Dysregulation and Neuroinflammation in Endometriosis: Convergent Druggable Pathways.

Endometriosis is a chronic, estrogen-dependent disorder defined by ectopic endometrial-like tissue growth, persistent inflammation, and aberrant innervation. Emerging evidence indicates that disease progression and symptom severity are driven by a …

Published: May 19, 2026, midnight
Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - BioSpace

Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update BioSpace

Published: May 18, 2026, 1:17 a.m.
Dry Eye-Related Ocular Surface Assessment in a Pooled Endometriosis/Adenomyosis Cohort: A Real-World Case-Control Study.

Background/Objectives: To explore potential dry eye-related ocular surface functional alterations in women at the time of first diagnosis of endometriosis or adenomyosis in a real-world clinical setting. Methods: This was …

Published: May 18, 2026, midnight
Endometriosis as a determinant of work disability in the Hungarian population: quantifying productivity loss and the need for workplace prevention strategies.

To quantify the impact of endometriosis on work productivity and work ability and to identify modifiable workplace targets for prevention-oriented strategies.

Published: May 18, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!